Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

If you are wondering whether Abbott Laboratories is offering fair value at around US$112.65 per share, you are not alone. This article is designed to help you make sense of what that price might ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

"Boring" may be just what the doctor ordered in this volatile market.

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30 per share was in line with analysts’ ...

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by Abbott Laboratories caused their premature infants to develop a dangerous bowel ...

The stock's fall snapped a three-day winning streak.

You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...